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Abstract
Capsules frequently play a key role in bacterial interactions with their environment. Escherichia coli capsules were
categorized as groups 1 through 4, each produced by a distinct mechanism. Etk and Etp are members of protein families
required for the production of group 1 and group 4 capsules. These members function as a protein tyrosine kinase and
protein tyrosine phosphatase, respectively. We show that Etp dephosphorylates Etk in vivo, and mutations rendering Etk or
Etp catalytically inactive result in loss of group 4 capsule production, supporting the notion that cyclic phosphorylation and
dephosphorylation of Etk is required for capsule formation. Notably, Etp also becomes tyrosine phosphorylated in vivo and
catalyzes rapid auto-dephosphorylation. Further analysis identified Tyr121 as the phosphorylated residue of Etp. Etp
containing Phe, Glu or Ala in place of Tyr121 retained phosphatase activity and catalyzed dephosphorylation of Etp and Etk.
Although EtpY121E and EtpY121A still supported capsule formation, EtpY121F failed to do so. These results suggest that
cycles of phosphorylation and dephosphorylation of Etp, as well as Etk, are involved in the formation of group 4 capsule,
providing an additional regulatory layer to the complex control of capsule production.
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Introduction
Bacteria frequently produce polysaccharide capsules that play a
significant role in various processes. Capsules contribute to biofilm
formation by providing an extracellular matrix component [1],
and are involved in interbacterial competition in some bacteria by
forming a shield that protects from contact-dependent killing by
other bacteria [2]. Capsules also play a role in virulence by several
mechanisms including inhibition of phagocytosis and formation of
a ‘‘decoy’’ for anti-bacterial peptides [3]. Furthermore, capsules
were implicated in controlling the activity of surface components,
such as adhesins or type III secretion apparatus, by regulated
masking and unmasking of these surface structures [4,5]. Escherichia
coli can synthesize capsule by four distinct mechanisms categorized
as groups 1 through 4. The group 1 and group 4 capsules are
produced by a similar Wzy-dependent mechanism [6]. This
mechanism involves the synthesis in the cytoplasm of lipid-linked
repeat units consisting of several sugar residues, followed by
translocation of the repeat unit to the outer leaflet of the inner
membrane [7]. The translocated repeat units serve as substrates
for the Wzy polymerase, which catalyzes the elongation of the
polysaccharide [7]. The capsule polysaccharide (sometimes termed
K-antigen) of a given E. coli strain is normally distinct from that of
its lipopolysaccharide (LPS) O-antigen repeats. In contrast, the
group 4 capsule is comprised of the same O-antigen repeats as
LPS. Thus, the group 4 capsule was also termed O-antigen capsule
[8].
The Wzy-mediated capsule synthesis is dependent on several
additional proteins including Wzc for group 1, and Etk for group 4
capsule [8,9,10]. Wzc and Etk are members of the bacterial
tyrosine autokinase family. Although they are transmembrane
proteins, they are structurally distinct from eukaryotic transmem-
brane kinases. Wzc and Etk form a hairpin structure, consisting of
a large periplasmic domain connected by two transmembrane
helices to cytoplasmic N- and C-terminal domains [7,11]. The
cytoplasmic C-terminal domain includes a catalytic protein
tyrosine kinase (PTK) domain and tyrosine-rich C-terminal ‘‘tail’’,
which is a substrate for the catalytic domain [6,12]. Autophos-
phorylation in trans is required for group 1 capsule formation as
mutation of the conserved Walker motif in Wzc abolished both
autophosphorylation and capsule assembly [9,10]. The Wzc and
Etk genes are preceded by genes encoding low-molecular-weight
protein tyrosine phosphatases (LMW-PTP), Wzb and Etp,
respectively, which can use their cognate PTK as substrates. It
was proposed that alternating cycles of phosphorylation and
dephosphorylation of the Wzc tyrosine-rich tail are required for
capsule production [7], but the specific mechanism by which this
phosphorylation influences capsule production has yet to be
defined. Recent crystallographic studies show that the nonpho-
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disrupted following phosphorylation, potentially causing the Wzc
periplasmic domains to cycle between two states [13]. Further-
more, Wzc and related proteins also promote polysaccharide
synthesis by phosphorylation of substrates other than the tyrosine-
rich tail in order to activate sugar nucleotide precursor biosyn-
thesis or activate glycosyl transferases [14].
LMW-PTPs similar to Wzb and Etp frequently occur in
prokaryotes and eukaryotes. These enzymes characteristically
function via a conserved cysteine, which serves as nucleophile, and
an invariant aspartic acid located in a DPY or DPYY conserved
loop. The eukaryotic LMW-PTPs are involved mainly in signal
transduction and their activity is subject to stringent regulation.
For instance, oxidation of the catalytic cysteine thiol inhibits their
enzymatic activity in a reversible manner [15]. The activity of
eukaryotic LMW-PTPs are also regulated by phosphorylation of
tyrosine residues in the DPYY loop (Tyr131 and Tyr132). Tyr131
phosphorylation may modulate its enzymatic activity [16,17], and
Tyr132 phosphorylation may provide substrate specificity [18].
The tyrosine residue in the DPY loop of Wzb/Etp was also
implicated in substrate recognition [19].
In this report, we analyze the involvement of Etk and Etp in
synthesis of group 4 capsule by enteropathogenic E. coli (EPEC).
We show that cycling of Etk phosphorylation and dephosphory-
lation by Etp is required for formation of group 4 capsule. We
further show that Etp is also subject to tyrosine phosphorylation,
that Etp’s phosphorylated residue is Tyr121, and, like Etk, Etp also
cycles between phosphorylated and unphosphorylated forms.
Mutagenesis data, both in vivo and in vitro, support the notion that
tyrosine phosphorylation of Etp is required for the formation of
group 4 capsule. These findings elucidate an additional regulatory
layer of capsule synthesis.
Results
Etk kinase activity is required for formation of group 4
capsule
We first tested whether the Etk catalytic activity is required for
production of group 4 capsule. To this end, we constructed a
plasmid expressing inactive Etk. The invariant Lys 545 of Etk,
which is essential for kinase activity, was replaced by methionine.
Plasmids expressing wild-type Etk or the mutated Etk (EtkK545M)
were introduced into EPEC, in which the native etk gene was
inactivated (etk::kan), and the ability of the plasmids to restore
capsule production was tested. First, we confirmed that the
bacteria equally expressed both Etk and EtkK545M and that
EtkK545M had lost its autokinase activity (Fig. 1A). Next, we
extracted polysaccharides from the bacteria, purified the capsular
polysaccharide without any LPS contamination, and probed by
dot blot with anti-O127 antibody. The results confirmed that wild
type EPEC produced capsular O127 polysaccharide, but the
etk::kan mutant failed to do so. Capsule production was restored by
a plasmid expressing Etk, but not by the plasmid that expressed
EtkK545M (Fig. 1B). These results suggested that the catalytic
activity of Etk is essential for production of group 4 capsule.
Etp dephosphorylates Etk in vivo and is tyrosine
phosphorylated
To test if Etp can dephosphorylate Etk in vivo, we transformed
EPEC with a plasmid encoding 6His-Etp (pAP406) and expressed
the recombinant Etp in LB at 20uC without shaking (conditions
that enhanced Etp solubility). As control, we used wild type EPEC
that did not express the recombinant Etp. Proteins were extracted
from the two strains and analyzed by Western blot with anti-Etk,
anti-6His and anti-phosphotyrosine (anti-PY) antibodies. The
results show a clear decrease in tyrosine phosphorylated Etk upon
Etp overexpression (Fig. 2), suggesting that Etp dephosphorylates
Etk in vivo. Intriguingly, we noticed that the anti-PY antibody also
reacted with the recombinant Etp (Fig. 2), indicating that some of
the Etp was tyrosine phosphorylated. We also noted that the
blotted Etp regained some of its acid-phosphatase activity during
the blot development to catalyze autodephosphorylation (Fig. S1).
To reduce the autodephosphorylation activity, blots were devel-
oped at pH 8 to inhibit Etp (Fig. S2). To exclude the possibility
that the anti-PY antibody recognized Etp by nonspecific cross-
reaction, we included the PY competitive inhibitor phenylpho-
sphate that abolished the antibody interaction with Etk (Fig. S3).
Taken together, our results show that Etp becomes tyrosine
phosphorylated in vivo and that it catalyzes autodephosphorylation.
The Etp phosphorylated residue is Tyr121
Comparison of Etp to other LMW-PTPs associated with
polysaccharide production highlighted only one conserved tyrosine
residue, Tyr121, located in the conserved DPY motif (Fig. 3A, B)
that also included the essential catalytic acid Asp119. To test
whether Tyr121 is the Etp phosphorylation site, we constructed
plasmids expressing Etp mutants. Prior to plasmid construction,
we determined the actual N-terminus of Etp, since early versions
of the EPEC genome sequence annotated the etp ORF starting at a
GTG codon, 5 codons prior to an ATG codon. To resolve which
codon was the native translation start site, we cloned etp including
the 80 bp upstream of the putative GTG initiation codon that
contained the etp native ribosomal binding site. In addition, we
added a hexahistidine (6His) tag to the 39 end of the etp ORF
followed by a stop codon. The generated plasmid pCNY506,
encoding Etp-6His, was introduced into E. coli and the expressed
Etp-6His was purified by affinity chromatography. The native N-
terminal sequence of the purified protein was determined to be
Figure 1. Etk K545M mutant failed to support capsule
production. EPEC strains, including wild type, etk::kan mutant and
the mutant complemented with plasmids pOI277 (pEtk) or pMS3239
(pEtk K545M), were grown under conditions that allowed capsule
production. After harvesting, proteins and capsular polysaccharide were
extracted. (A) The amount of Etk and phosphorylated Etk were assessed
by Western blot using anti-Etk and anti-phosphotyrosine (anti-PY)
antibodies. Each lane is labeled with the strain (above blot) and
antibody (on left). (B) Purified capsular polysaccharide extracted from
bacteria was serially diluted to generate a dot blot that was developed
with anti-O127 antibody. Wild-type EPEC and etk mutant were used as
positive and negative controls, respectively. The strains are indicated
above each serial dilution.
doi:10.1371/journal.pone.0037984.g001
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starts at the first ATG of the ORF rather than the GTG. We thus
termed the ATG encoded residue as Met1. We further used this
vector to generate Etp mutants in the DPY motif.
We next expressed the constructed Etp mutants, EtpD119A and
EtpY121F, in the EPEC Detp::kan strain, and examined whether
they were tyrosine phosphorylated. Our results showed that
EtpD119A was deficient in phosphatase activity, and became
hyperphosphorylated due to Etp’s inability to dephosphorylate
itself (Fig. 3C). In contrast, EtpY121F was completely unpho-
sphorylated suggesting that Y121 is the phosphorylated residue.
EtpY121F maintained its phosphatase activity as indicated by its
capacity to dephosphorylate Etk in vivo (Fig. 3C). To confirm this
catalytic activity, we measured the in vitro ability of Etp and
EtpY121F to dephosphorylate the cytoplasmic catalytic domain of
phosphorylated Etk. Again, Etp and EtpY121F exhibited similar
activity (Fig. 3D and Table 1). To further exclude the possibility
that EtpY121F is not phosphorylated simply due to increased
autodephosphorylation in vivo, we constructed a plasmid expressing
Etp where both D119 and Y121 were mutated (to give
EtpDPY.APF). This protein was not phosphorylated although
it was deficient in phosphatase activity as indicated by reduced
dephosphorylation of Etk (Fig. 3C). Taken together, these results
indicated that Etp Tyr121 becomes phosphorylated in vivo.
We noticed that Etp phosphorylation was not restricted to
EPEC and was also observed in other E. coli strains. We took
advantage of this observation to further examine the finding that
Figure 2. Etp promotes Etk dephosphorylation and is tyrosine
phosphorylated in vivo. EPEC strains transformed, or not trans-
formed, with plasmid pAP406 (p6His-Etp) expressing 6His-Etp, were
grown overnight in LB at 20uC without shaking. The bacteria were
harvested, and the extracted proteins were separated for Western blot
analysis with anti-Etk, anti-phosphotyrosine (anti-PY), and anti-6His
antibodies. The corresponding antibody is indicated above each panel.
Also indicated are the location of Etk and 6His-Etp and the molecular
size markers (at the right). Whether a given strain contained the pEtp
plasmid is indicated below each lane.
doi:10.1371/journal.pone.0037984.g002
Figure 3. Identification of the phosphorylated Etp residue. (A) The region containing the DPY motif (in bold) of Etp is compared with the
corresponding region of several members of the LMW-PTP family. They include AmsI of Erwinia amylovora, the E. coli-encoded Etp paralog Wzb, Yco5
of Klebsiella pneumoniae, EspP of Ralstonia solanacearum, the human PA1F protein, and the bovine PPAC protein encoded by the ACP1 gene.
Numbering is according to the Etp sequence. (B) Homology model of the Etp structure in the absence of bound substrate based on the NMR
structure of Wzb [19]. Side chains Tyr121 and Asp119 are shown in sticks. The phosphate binding loop (yellow) and catalytic cysteine C13 are in the
center. (C) EPEC mutant Detp::kan was transformed with plasmids expressing different Etp mutants all of which had C-terminal 6His tags. Proteins
were extracted from the different cultures and were subjected to Western blot analysis with anti-Etk, anti-6His and anti-PY antibodies as indicated.
The corresponding strain is indicated above each of the lanes. (D) In vitro kinetics of Etp and variants with phosphorylated MBP-Etk as substrate. The
graph plots the rate of inorganic phosphate produced versus substrate concentration for Etp, EtpY121F, and EtpD119E. Kinetic constants are in
Table 1.
doi:10.1371/journal.pone.0037984.g003
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pAJ0046 in E. coli BL21(DE3) and purified. Western blotting with
anti-phosphotyrosine antibody 4G10 (Millipore/Upstate) con-
firmed that the protein was hyper-phosphorylated when compared
to wild type Etp (data not shown). The purified protein was
analyzed by electrospray tandem mass spectrometry (LC-MS/MS)
by MS Bioworks, LLC (Ann Arbor MI). The size of peptides that
included Tyr121 as well as their fragmentation patterns conclu-
sively showed the presence of a phosphorylated tyrosine (+80
a.m.u.) corresponding to position 121 of the native protein (Fig. 4).
This was observed in 31 of 64 spectra of peptides containing
Tyr121. Fig. 4 is a typical spectrum showing C-terminal fragments
before (y3) and after (y2) the phosphorylated Tyr121. No tyrosine
phosphorylation was observed elsewhere in the protein.
EtpY121F is deficient in supporting capsule formation
We next tested whether Etp phosphorylation on Tyr121 plays a
role in capsule formation. The general strategy was to generate
different point mutations in a plasmid encoding Etp with 6His at
its C-terminus. The different constructed plasmids were then
tested for the ability to complement EPEC Detp::kan by restoring
Etk dephosphorylation, autodephosphorylation and rescue of
capsule formation. The Etp mutants included i) EtpY121F,
mimicking the Etp unphosphorylated form; ii) EtpY121E,
mimicking the Etp phosphorylated form; and iii) EtpY121A,
lacking both the charge and phenolic ring. As negative controls we
included in this analysis EtpD119A and EtpD119E, which exhibit
severe and moderate attenuation in phosphatase activity, respec-
tively. As an additional control we used EtpDPY.APF. Similar
expression levels of all Etp mutants were confirmed by Western
blots with anti-6His antibody (Fig. 5A).
Our results showed that the phosphatase activity of EtpD119A
and EtpDPY.APF were strongly attenuated as judged by their
inability to dephosphorylate Etk or catalyze autodephosphoryla-
tion (EtpD119A) (Fig. 5A). EtpD119E activity was partially
attenuated as seen by partial autodephosphorylation and de-
creased dephosphorylation of Etk. Unlike EtpD119A that was
inactive in the in vitro Etp dephosphorylation assay (data not
shown), EtpD119E had low activity (Fig. 3D), consistent with the in
vivo results. These three Etp mutants also failed to produce
significant capsule polysaccharide (Fig. 5B). Surprisingly, the
mutant expressing EtpY121F, which in vivo and in vitro showed
similar phosphatase activity towards Etk as wild-type Etp (Fig. 5A,
3D and Table 1), also failed to produce capsule (Fig. 5B). Etp
containing other substitutions of Tyr121, including EtpY121E and
EtpY121A, exhibited both phosphatase activity and rescue of
capsule production, albeit at efficiencies slightly lower than that of
wild type Etp (Fig. 5).
Taken together, our results indicate that the catalytic activity of
Etp is essential for production of O127 group 4 capsule, probably
due to the need to dephosphorylate Etk. Furthermore, the results
show that Tyr121 per se, is not required for capsule formation or
for phosphatase activity. However, expression of EtpY121F, which
mimics the nonphosphorylated form of Etp, inhibits capsule
formation by a mechanism unrelated to the phosphorylation state
of Etk. Assuming that EtpY121F and EtpY121E mimic the
dephosphorylated and phosphorylated forms of Etp, respectively,
our results suggest that nonphosphorylated Etp inhibits capsule
formation and Etp phosphorylation on Tyr121 alleviates this
inhibition.
Table 1. In vitro kinetics of MBP-Etk dephosphorylation by
6His-Etp and 6His-EtpY121F.
kcat sec
21 KM (mM) kcat/KM (sec mM)
21 (610
23)
Etp wild type 2.84 24.8 115
EtpY121F 2.86 34.9 82
doi:10.1371/journal.pone.0037984.t001
Figure 4. ESI tandem mass spectrometry confirms the presence and location of the phosphorylated tyrosine. The ESI-MS/MS
fragmentation spectrum of Etp peptide GKTMLFGQWLEQKEIPAP(pY)RK (residues 113–123, pY is the phosphorylated tyrosine). The parent peptide
was a +4 H ion with mass 2599.29 amu (20.0134 amu from predicted size). The schematic at the top of the figure shows the identified y fragments
referred to in the spectra. All of the y fragments include the peptide’s C-terminus and have masses consistent with the phosphorylated Y121 (pY)
residue. For example, the m/z for fragments y3 and y2 are 546.2 and 303.2, respectively. The difference 243 is the exact mass of a phosphotyrosyl
residue. The labeled b fragments originate at the N-terminus of the peptide but do not include the pY residue.
doi:10.1371/journal.pone.0037984.g004
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We next tested whether Etk is the tyrosine kinase that
phosphorylates Etp in vivo. We transformed EPEC containing an
inactivated etk gene (EPEC etk::kan) and the EPEC double mutant
etk::kan, etp::cm with a plasmid expressing EtpD119A, and
compared EtpD119A phosphorylation between the two strains.
The results showed that EtpD119A becomes phosphorylated even
in the EPEC etk::kan mutant (Fig. 6). The only other known PTK
encoded by E. coli strains including EPEC is Wzc. We thus
constructed the triple mutant etp::cm, etk::kan, wzc::tet and tested the
capacity of this strain to phosphorylate EtpD119A. Notably, also
in this case the EtpD119A remained phosphorylated (Fig. 6).
Taken together our results indicate that neither Etk nor Wzc is
essential for Etp phosphorylation and that the identity of the
kinase that phosphorylates Etp remains unknown.
Figure 5. EtpY121F retained phosphatase activity but failed to support capsule formation. (A) Proteins were extracted from wild-type
EPEC, the Detp::kan mutant, or mutant complemented with plasmids derived from pEtp (pCNY506) and expressing different Etp variants with C-
terminal 6His tags. The levels of Etk, phosphorylated Etk, recombinant Etp, and phosphorylated Etp were determined by Western blot analysis using
anti-Etk, anti-6His, and anti-PY antibodies. The strain and the complementing mutant of Etp are indicated above the blots and the antibodies used in
the immunoblots are indicated on the left side. The levels of Etk dephosphorylation and Etp autodephosphorylation are indicated below the blots. (B)
Capsule polysaccharide was extracted and purified from the same strains presented in (A). Two-fold serial dilutions of purified capsule were dotted on
PVDF and developed with anti-O127 antibody. The identity of the strain and complementing plasmid are indicated above the blot and direction of
capsule polysaccharide dilution is indicated at the right side of the blot.
doi:10.1371/journal.pone.0037984.g005
Figure 6. Etk and Wzc are not essential for Etp phosphoryla-
tion. EtpD119A was expressed in different EPEC strains with deletions
in the etp gene and the kinase genes etk and wzc. Proteins were
extracted and the amount and phosphorylation state of Etp were tested
by Western blot using anti-6His and anti-PY antibodies, respectively.
The presence of intact genes is indicated above the lanes.
doi:10.1371/journal.pone.0037984.g006
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The etp and etk genes are the last genes of a group 4 capsule
operon found in most E. coli strains that includes seven genes:
gfcABCDE, etp and etk (formerly ymcDCBA, yccZ, yccY and yccC,
respectively) [8]. The Etk autokinase, in analogy to its close
paralog Wzc, is predicted to function as a component of a larger
protein complex that transverses the bacterial envelope and forms
a polysaccharide secretion system [7]. Wzc, and probably also Etk,
form a tetrameric [20] or octameric [13] complex that crosses the
inner membrane and interacts through its periplasmic domains
with the outer membrane protein octamer Wza, a member of the
OPX (outer membrane polysaccharide export) family [7]. Wza
oligomers are both in contact with Wzc and form a channel-like
structure in the outer membrane [7]. Since Etk and GfcE are very
similar to Wzc and Wza (51% and 64% sequence identity,
respectively), it is likely that Etk and GfcE form a complex similar
to that formed by Wzc and Wza. Additional components in these
systems are Wzb (for group 1) or Etp (for group 4 capsule), both
LMW-PTPs that target Wzc and Etk, respectively [9,10, this
study]. Our results and results of others suggest that phosphory-
lation and dephosphorylation cycling of at least the kinase
carboxyl terminus is crucial for the proper functioning of the
Wzc-dependent system and thus for formation of group 1 capsule
[7]. In this report we show for the first time that Etp
dephosphorylates Etk in vivo and that mutations which abolish
either the catalytic activity of Etk or Etp result in a deficiency in
the synthesis of group 4 capsule. These results also suggest that
alternating cycles of Etk phosphorylation and dephosphorylation
are required for group 4 capsule formation. These new data
extend the similarity between the mechanisms involving the
synthesis of group 1 and group 4 capsules.
Unexpectedly, we noticed that Etp became tyrosine phosphor-
ylated in vivo. Further analysis defined Tyr121, located within a
DPY motif, as the phosphorylated residue. Interestingly, Tyr121
was implicated in substrate recognition by Wzb, the Etp close
homolog [19]. Furthermore, in eukaryotic LMW-PTPs, Tyr131
and Tyr132 within the DPYY motif, which corresponds to the
DPY motif of Etp, are subjected to phosphorylation [16]. These
eukaryotic LMW-PTPs, and likely also Etp, may catalyze
autodephosphorylation by forming transient dimeric structures
[21]. Phosphorylation of eukaryotic LMW-PTP was previously
implicated in regulation of its activity [16,17].
Biochemical analysis of the intrinsically unstable tyrosine
phosphorylation of Etp is challenging. We thus adopted an
alternative approach to deepen our insight as to the role of Etp
phosphorylation by generating mutants that might mimic either
the Etp phosphorylated form (EtpY121E) or unphosphorylated
form (EtpY121F), or test the importance of the phenolic ring of
Tyr121 (EtpY121A). Notably, all Etp Y121 mutants exhibited
PTP activity in vivo similar to that of the wild type Etp, but while
EtpY121E and EtpY121A also supported capsule production,
EtpY121F failed to do so. These results indicate that like Etk, Etp
cycles between phosphorylated and dephosphorylated forms
during capsule production. Furthermore, the results suggest that
the unphosphorylated Etp may inhibit capsule formation, regard-
less of its phosphatase activity, and that this inhibition is alleviated
upon Etp phosphorylation.
Based on our results we propose the model shown in Fig. 7. This
model and our study raise several new questions. First, why does
EtpY121F with near wild-type catalytic activity inhibit capsule
formation? One possibility is that the Y121F substitution alters the
enzyme’s substrate specificity. If this is the case, the affected
substrate is likely not Etk, since our results showed that EtpY121F
dephosphorylated Etk as efficiently as wild-type Etp. UDP-glucose
dehydrogenase (Ugd) has been described to be a substrate of Wzc/
Wzb proteins in E. coli [14]. By analogy, if Etp dephosphorylates
Ugd, the Y121F substitution could affect substrate recognition of
Ugd. Why Etp phosphorylation alleviates this inhibitory effect
must also be addressed. A second possibility is that Phe121 affects
the interaction of EtpY121F with other Etp molecules or with
another protein affecting its function. Interestingly, a Bacillus
subtilis LMW-PTP, whose sequence contains Phe in place of Etp’s
Tyr121, was observed by NMR to oligomerize at sub-millimolar
concentrations [21].
How Etp is phosphorylated is another important unanswered
question. Etk and Wzc are not essential for Etp phosphorylation,
but might contribute to this activity. Nevertheless, our data suggest
that another putative E. coli kinase phosphorylates Etp, adding an
additional layer of regulation to capsule production. A likely
candidate might be a bacterial P-loop ATPase, like MinD, ParA,
or ArsA, that share catalytic and structural similarities to Etk and
Wzc [12].
Materials and Methods
Bacterial strains and plasmids
Table 2 shows the EPEC strains used in this study. Bacteria
were grown in Luria Broth (LB), or in LB without NaCl where
Figure 7. A model for the role of Etp and Etk in capsule
formation. Cycling of Etk phosphorylation and dephosphorylation are
required for capsule production (arrow 1). This cycling is mediated by
the autokinase and autophosphatase activities of Etk and Etp,
respectively (arrows 2 and 3). Etp also cycles between phosphorylated
and unphosphorylated forms and this cycling is catalyzed by Etp
autodephosphorylation (arrow 4) and a yet to be defined kinase (arrow
5). Etp cycling per se is not required for capsule formation. However,
based on our results we hypothesize that the unphosphorylated Etp
has an inhibitory effect on capsule formation (arrow 6), which can be
removed by Etp phosphorylation.
doi:10.1371/journal.pone.0037984.g007
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tration according to text), ampicillin (Amp) 100 mg/ml, kanamycin
(Kan) 40 mg/ml, and chloramphenicol (Cm) 25 mg/ml were added
to the growth media as needed. Bacterial strains were constructed
using the lambda Red method as described [22]. The plasmids
and primers used in this study are listed in Table 3 and Table 4,
respectively. To generate pKS2084, the etk reading frame
encoding the catalytic domain (residues 446–726) was amplified
by PCR and cloned into pSJ8 previously digested with BamHI and
XhoI. The resulting plasmid encoded the maltose-binding protein
(MBP) followed by an 86His tag, TeV protease site, and Etk
residues 446–726. Etp and Etk point mutations were generated
with the QuikChange Site-Directed Mutagenesis Kit (Stratagene).
In all cases DNA sequencing verified the presence of the desired
mutations and lack of other mutations.
Purification of Etp-6His and N-terminal sequencing
An overnight culture of E. coli XL1B containing pCNY506,
expressing Etp-6His from the etp native promoter, was diluted
1:100 in 500 ml LB and incubated at 37uC with shaking. Upon
reaching an optical density (OD600) of 0.6, the culture was
centrifuged (4,100 g, 7 min) and the pellet was re-suspended in
4 ml lysis buffer containing 6 M guanidinium hydrochloride,
20 mM Tris-HCl pH 8, 100 mM NaCl, 0.5% Triton-X100 and
100 ug/ul PMSF. After 30 min of incubation the lysate was
sonicated and clarified by repeated centrifugations (36,400 g,
7 min). The clear lysate was subjected to metal affinity chroma-
tography using 200 ml of Talon beads (Clontech Inc.). Etp-
containing fractions were electrophoresed on a 15% SDS-PAGE
gel, transferred to PVDF membrane (Whatman, Inc.), and stained
with Coomassie Blue. The gel band containing Etp-6His was
excised and sequenced by Edman degradation with a Perkin
Elmer (Applied Biosystems) model 492 sequencer system.
Immunoblot analysis
Samples were separated by SDS-PAGE and transferred to
nitrocellulose membrane. The membrane was washed briefly with
TBS-pH 8 (150 mM NaCl, 20 mM Tris-HCl pH 8) and blocked
for two hours with 5% bovine serum albumin (BSA, Sigma) and
0.01% Tween-20 (Sigma) in TBS-pH 8. When needed, blocking
solutions of different pH were used as indicated. The blots were
then developed with monoclonal anti-PY (PT66 Sigma), anti-6His
(clone 6H, Sigma), anti-OK127 (Statens Serum Institut, Denmark)
as anti-O127, or polyclonal rabbit anti-Etk antibodies [11] diluted
in TBS-pH 8 containing 1% BSA. Anti-mouse IgG or anti-rabbit
IgG conjugated with alkaline phosphatase (Sigma) or horseradish
Table 2. Enteropathogenic E. coli strains.
EPEC strains Description Reference
E2348/69 EPEC O127:H6, a clinical isolate [23]
AP2417 E2348/69 Detp::kan [8]
AP1104 E2348/69 Detp::cm [8]
OI899 E2348/69 etk::kan [11]
AP1417 E2348/69 Detp::cm etk::kan This study
CNY3101 E2348/69 Detp::cm etk::kan Dwzc::tet This study
doi:10.1371/journal.pone.0037984.t002
Table 3. Plasmids.
Name (stock#) Description Reference/source
pOI277 pACYC184 containing lacI
q and 6his-etk under control of the tac promoter [11]
pMS3239 pOI277 expressing the K545M inactive mutant This study
pSJ8 pET21a with MBP-8His-(TeV protease cleavage site)- upstream of cloning site Zhaohui Xu
pKS2084 pSJ8 expressing MBP-8His-TeV-Etk(446–726), amplified from pOI277 with primers 207
and 45
This study
pET28b Expression vector with T7 promoter Novagen
pMS0125 pET28b expressing 6His-TeV-Etp This study
pAJ0046 pMS0125, expressing 6His-EtpD119A This study
pAJ0049 pMS0125, expressing 6His-EtpY121F This study
pAJ2090 pMS0125, expressing 6His-EtpD119E This study
pSA10 Expression vector with tac promoter [24]
pCNY506 (2723) pSA10 carrying etp, with 80 bp upstream region and 6His at C-terminus. This study
pCNY507 (2790) pCNY506, expressing EtpD119A This study
pAJ3242 pCNY506, expressing EtpD119E This study
pCNY508 (2792) pCNY506, expressing EtpY121F This study
pCNY512 (3139) pCNY506, expressing EtpY121E This study
pCNY513 (3152) pCNY506, expressing EtpY121A This study
pCNY510 (2967) pCNY506, expressing EtpD119A, Y121F This study
pAP406 pQE31 containing lacI
q and expressing 6His-Etp [8]
pKD4 Template for amplification of Kan cassette [22]
pKD46 Temperature-sensitive plasmid encoding lambda Red genes [22]
doi:10.1371/journal.pone.0037984.t003
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tion was done with NBT/BCIP (Promega) or ECL substrate
(Promega), respectively.
Mass spectroscopy analysis
To prepare His6–Etp(D119A) for mass spectroscopy, E. coli
BL21(DE3) transformed with plasmid pAJ0046 was grown in
Terrific Broth at 37uC, cooled for 30 min at 20uC, then induced
with 0.2 mM IPTG. Cells were lysed by sonication in 300 mM
NaCl, 2 mM TCEP, 2 mM sodium orthovanadate, 50 mM
sodium phosphate, pH 7.4. Following metal affinity chromatog-
raphy of the soluble fraction with TALON Superflow resin
(Clontech), the purified protein was run on a 15% SDS-PAGE gel
and stained with Thermo GelCode
TM Blue Safe stain. The major
band corresponding to His6-Etp(D119A) was excised, washed with
25 mM ammonium bicarbonate followed by acetonitrile, reduced
with 10 mM dithiothreitol at 60uC, and alkylated with 50 mM
iodoacetamide at 22uC. The sample was then digested with
sequencing grade trypsin (Promega) at 37uC for 4 hr, quenched
with formic acid, and the supernatant was analyzed directly
without further processing. The sample was analyzed by nano
LC/MS/MS at MS Bioworks, LLC (www.msbioworks.com) with
a Waters NanoAcquity HPLC system interfaced to a Thermo-
Fisher LTQ Orbitrap Velos. Peptides were loaded on a trapping
column and eluted over a 75 mm analytical column at 350 nL/
min; both columns were packed with Jupiter Proteo resin
(Phenomenex). The mass spectrometer was operated in data-
dependent mode, with MS performed in the Orbitrap at 60,000
FWHM resolution and MS/MS performed in the LTQ. Peptides
were identified that represented 98% of the predicted sequence. A
second analysis by higher energy collision induced dissociation
produced 48 unique peptides and 545 total spectra. There were 56
phosphopeptide spectra of which 14 were unique. All runs were
analyzed by Scaffold (Proteome Software) for validation, filtering,
and to create a non-redundant list per sample.
Purification of polysaccharide capsule and dot-blot
analysis
Bacteria were grown overnight without shaking at 30uCi n
NaCl-free LB media supplemented with 20 mM (NH4)2SO4 and
5 mM MgSO4. Cultures were diluted 1:2500 into 100 ml LB in a
500 ml flask and incubated overnight under the same conditions.
Cells were harvested by centrifugation at 4,000 rpm (3,220 g) for
15 min at room temperature. Pellets were washed with 20 ml of
phosphate-buffered saline (PBS), resuspended in 1 ml PBS,
transferred to 2 ml Eppendorf tubes, centrifuged at 5,000 rpm
(2,655 g) for 5 min at room temperature, and finally suspended in
0.9 ml of PBS. Then, an equal volume of phenol pH 8 was added
Table 4. Oligonucleotide primers used in this study.
No. Primer Sequence (59 to 39)* Use
424 GCGAATTCCCGCTGGCTCGTTGGAACCG Forward primer for creating pCNY506
425 GCGTCGACTTAGTGATGGTGATGGTGATGCCGGCTGAGGCGCTTCGC Reverse primer for creating pCNY506
225 CTATCCGCATATGGCCCAACTAAAATTTAAC Forward primer for creating pMS0125
226 CGACTCGAGTTACCGGCTGAGGCGCTTCG Reverse primer for creating pMS0125
207 CGTGGGATCCCGTGCGATGTTGCGTCGTG Forward primer for creating pKS2084
45 GATCTCGAGTCACTCTTTCTCGGAGTAACTATAAC Reverse primer for creating pKS2084
263 ACCGTCAATGGTATGGTC Forward primer for creating etk::kan in AP1417
264 CGTTTTACCACTGTCTGG Reverse primer for creating etk::kan in AP1417
475 CGGGAAACGTTTGCAGCGGTGTACACATTACTTGAACGGTCTGCCCGCCAcaagagggtcattatatttcg Forward primer for creating Dwzc::tet
476 AGGTAGGTCGGATAAGATGCGTCAGCATCGCATCCGACAGCGGATGTCGactcgacatcttggttaccg Reverse primer for creating Dwzc::tet
480 GAAAGAGATCCCGGCTCCCTATCGTAAAAG Forward primer for EtpD119A substitution in pCNY507
481 CTTTTACGATAGGGAGCCGGGATCTCTTTC Reverse primer for EtpD119A substitution in pCNY507
298 GATCCCGGATCCCTTTCGTAAAAGTCAGG Forward primer for EtpY121F substitution in pCNY508
299 CCTGACTTTTACGAAAGGGATCCGGGATC Reverse primer for EtpY121F substitution in pCNY508
460 GAAAGAGATCCCGGCTCCCTTTCG TAAAAG Forward primer for EtpD119A, Y121F substitutions in pCNY510
461 CTTTTACGAAAGGGAGCCGGGATC TCTTTC Reverse primer for EtpD119A, Y121F substitutions in pCNY510
437 GAGATCCCGGATCCCGAGCGTAAAAGTCAGGACG Forward primer for EtpY121E substitution in pCNY512
438 CGTCCTGACTTTTACGCTCGGGATCCGGGATCTC Reverse primer for EtpY121E substitution in pCNY512
493 GAGATCCCGGATCCCGCGCGTAAAAGTCAGGACG Forward primer for EtpY121A substitution in pCNY513
494 CGTCCTGACTTTTACGCGCGGGATCCGGGATCTC Reverse primer for EtpY121A substitution in pCNY513
58 CAGAAAGAGATCCCGGCTCCCTATCGTAAAAGTCAGG Forward primer for EtpD119A substitution in pAJ0046
59 CCTGACTTTTACGATAGGGAGCCGGGATCTCTTTCTG Reverse primer for EtpD119A substitution in pAJ0046
54 GAGATCCCGGATCCCTTTCGTAAAAGTCAGGACG Forward primer for EtpY121F substitution in pAJ0049
55 CGTCCTGACTTTTACGAAAGGGATCCGGGATCTC Reverse primer for EtpY121F substitution in pAJ0049
49 CAGAAAGAGATCCCGGAGCCCTATCGTAAAAGTCAGG Forward primer for EtpD119E substitution in pAJ2090, pAJ3242
48 CCTGACTTTTACGATAGGGCTCCGGGATCTCTTTCTG Reverse primer for EtpD119E substitution in pAJ2090, pAJ3242
*Underlined sequences represent restriction enzyme sites, and lower case sequences are regions complementary to the template plasmid containing the antibiotic
cassette.
doi:10.1371/journal.pone.0037984.t004
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at 70uC for 1 hr (mixing every 5 min) and then centrifuged at
14,000 rpm (12,000 g) at room temperature for 1 hr. The aqueous
fraction was phenol extracted three more times. Then samples
were extracted twice with an equal volume of chloroform and
centrifuged for 30 min at 14,000 rpm (12,000 g). The upper,
aqueous phase was recovered, two volumes of 100% ethanol were
added to each sample, and the polysaccharides was allowed to
precipitate for 1 h at 270uC. Next, the samples were centrifuged
at 12,000 g for 30 min, after which the pellets were washed with
500 ml of 70% ethanol, recentrifuged, and dried. Pellets were
dissolved in 0.6 ml water at 65uC. The dissolved capsular and LPS
material were transferred to ultracentrifuge tubes (Beckman
357448) and centrifuged at 55,000 rpm (186,000 g) in a Beckman
TL-100 microcentrifuge (TLA-55 rotor) at 4uC for 2 h with
controlled speed decline to pellet the LPS micelles. The top 400 ml
supernatant, containing capsular polysaccharide, was carefully
transferred to a new tube and the volume was reduced to 50 mlb y
centrifugal vacuum concentration (SpeedVac). Of the remaining
200 ml, the top ,140 ml was discarded and the bottom ,40 ml
containing LPS was kept. Samples were run on 10% SDS-PAGE
gels followed by Western blot with anti-O127 antiserum to analyze
the samples for LPS (2.5 ml per lane). The capsule polysaccharide
samples were serially diluted and 2.5 ml from each dilution were
dotted on PVDF membranes for Western blots. To ensure that the
capsular polysaccharide samples were not contaminated with LPS,
10 ml of the undiluted material was also analyzed by SDS-PAGE
and Western blot. Immunoblots were blocked (2% BSA and 2%
skimmed milk), and developed with rabbit OK anti-O127
antiserum (Statens Serum Institute) followed by a secondary
anti-rabbit IgG antibody conjugated to alkaline phosphatase
(Sigma A3687) and stained using the BCIP/NBT reagents
(Promega S3771).
Purification of MBP-Etk(446–726)
Ten milliliters of an overnight culture of BL21(DE3) previously
transformed with pKS2084 were diluted into 1 liter of LB-Amp,
grown to OD600<0.6 at 37uC, and cooled to 22uC with shaking.
IPTG (0.2 mM) was added and shaking continued at 22uC for 16–
18 hrs. After centrifugation, cells from 0.5 liter of culture were
resuspended in 30 ml buffer A (300 mM NaCl, 20 mM Tris-HCl
pH 8) containing one-half tablet of EDTA-free Protease Inhibitor
Cocktail (Roche). After lysis by sonication and centrifugation at
48,000 g, the supernatant was filtered and loaded on an 8 ml
Talon Superflow (Clontech) column and eluted with a gradient of
300 mM imidazole in buffer A. Fractions containing the fusion
protein were pooled, dialyzed against buffer A containing 10%
glycerol, concentrated, and frozen at 280u.
Determination of Etp activity using Etk as substrate
6His-Etp, 6His-EtpY121F, or 6His-EtpD119E were expressed
from BL21(DE3) containing pMS0125, pAJ0049, or pAJ2090 by
overnight incubation at 22uC. After chromatography of the soluble
fraction with Talon Superflow, Etp-containing fractions were
dialyzed against phosphate-buffered saline containing 2 mM
TCEP and 10% glycerol, and frozen at 280uC. Purified MBP-
Etk(446–726) was completely phosphorylated by incubation with
ATP and MgCl2 and to serve as substrate. Immediately before
assay, Etp and Etk samples were buffer exchanged into 200 mM
NaCl, 2 mM TCEP, 20 mM Tris-HCl, pH 7.5 by gel filtration in
order to remove all phosphate. Dephosphorylation assays in 96-
well trays monitored the release of inorganic phosphate by the
EnzChek enzyme-linked assay (Invitrogen). Reactions were set up
in 96-well trays at 37uC by mixing 50 ml 2-amino-6-mercapto-7-
methylpurine riboside, 2.5 ml purine nucleoside phosphorylase,
187.5 ml MBP-Etk substrate at varying concentrations (0–50 mM)
in Tris-HCl buffer (pH 7.5), and 10 ml Etp (5–25 mM). Data were
fit to the Michaelis-Menton equation with DeltaGraph (Red Rock
Software) to derive the kinetic constants.
Supporting Information
Figure S1 Etp autodephosphorylation. To prepare Etp, E.
coli XL1Blue containing pAP406 (p6His-Etp) was grown in LB at
37uCt oO D 600=0.5. After transfer of culture to 20uC for 30 min,
IPTG was added to a final concentration of 0.1 mM and the
culture was incubated 15 h at 20uC without shaking. The 6His-
tagged Etp was extracted and purified under native conditions
using Talon metal affinity chromatography according to the
protocols recommended by the manufacturer (Clontech). (A)
Purified Etp was incubated at pH 6 at 37uC. Aliquots were
removed at 0, 1, 5, and 10 min, mixed immediately with SDS
loading buffer, and boiled. The phosphorylation levels were tested
by Western blot analysis with anti-PY antibody. In (B), equal
amounts of purified and partially phosphorylated Etp were loaded
into four lanes and blotted onto nitrocellulose membrane. The
membrane was then sliced and different strips were incubated in
blocking solutions adjusted to different pH levels (6, 7, 8, and 9) for
6 hours. The membranes were then washed and developed with
anti-PY antibody. At pH 6 the signal was not detected indicating
that Etp was auto-dephosphorylated. A similar experiment is
shown in (C) but in this case all the blots were incubated at pH 6
and the incubation time with the blocking solution was varied (1, 2
and 3 h).
(TIF)
Figure S2 Etp activity at different pHs. Recombinant 6His-
Etp was purified as described in Fig. S1. In (A) the purity was
examined by running a SDS-PAGE gel followed by staining with
Coomassie Blue. Only one band was visualized (A, left lane).
Molecular weight markers are shown in the right lane. In (B) the
activity of the enzyme was determined under different pH
conditions, using p-nitrophenol phosphate (pNPP) as substrate.
Maximal activity was observed at pH 6, while the activity at pH 8
was very slow. Phosphatase activity was monitored at 37uC, using
a continuous method based on the detection of p-nitrophenol
formed from pNPP. Dephosphorylation rates were determined at
405 nm in a reaction buffer containing 0.4% PNPP and 100 mM
Tris-HCl at the desired pH. The assay was optimized with respect
to protein concentration, time, and pH.
(TIF)
Figure S3 Phenylphosphate inhibits binding of anti-PY
antibody to Etp. 6His-Etp was expressed in EPEC and purified
under alkali conditions as described in Fig. S1. The purified
protein was used for immunoblotting and reacted with anti-6His
(left panel), anti-PY (central panel) and anti-PY in the presence of
10 mM phenylphosphate (the right panel), a competitive inhibitor
of the interaction of anti-PY with phosphorylated tyrosine
residues. As shown, phenylphosphate completely inhibited binding
of the anti-PY antibody (right panel).
(TIF)
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